Aspira Women's Health Inc. - 8-K Filing
Aspira Women's Health Inc. filed a Form 8-K to disclose Michael Buhle's resignation as CEO effective June 17, 2026, and his subsequent separation agreement dated June 27, 2026. The company agreed to pay $200,000 in severance over six months, cover COBRA premiums for six months, and accelerate vesting of unvested stock options covering 64,583 shares at an exercise price of $0.07 per share.
Tickers: $AWH